Explore more publications!
Kentucky Tech Times
Got News to Share?

Kentucky Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kentucky Tech Times.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on March 1, 2026

Veea Platform Solution to Address Cybersecurity Challenges Nationwide for Businesses in Mexico
Mar. 1, 2026

Veea Platform Solution to Address Cybersecurity Challenges Nationwide for Businesses in Mexico

Indeterminate GlobeNewswire
Investor Education Webinar
Mar. 1, 2026

Investor Education Webinar

Indeterminate GlobeNewswire
Saabsoft Launches Integrated Real Estate Technology Platform for Developers and Brokers in the UAE
Mar. 1, 2026

Saabsoft Launches Integrated Real Estate Technology Platform for Developers and Brokers in the UAE

Indeterminate GlobeNewswire
Melbourne AI Agency Enterprise Monkey Quits ChatGPT Over Pentagon Deal
Mar. 1, 2026

Melbourne AI Agency Enterprise Monkey Quits ChatGPT Over Pentagon Deal

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
Mar. 1, 2026

Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire
CitrusBurn Strategy Examined: Is the Pink Gelatin Recipe the Real Secret to Weight Loss? Citrus Burn Facts!
Mar. 1, 2026

CitrusBurn Strategy Examined: Is the Pink Gelatin Recipe the Real Secret to Weight Loss? Citrus Burn Facts!

Indeterminate GlobeNewswire
Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and…
Mar. 1, 2026

Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and…

Indeterminate GlobeNewswire
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
Mar. 1, 2026

Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy

Indeterminate GlobeNewswire
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Mar. 1, 2026

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting

Indeterminate GlobeNewswire
OrganTech Defines Minimal Stem Cell Set Enabling Functional Hair Follicle Regeneration In Vitro
Mar. 1, 2026

OrganTech Defines Minimal Stem Cell Set Enabling Functional Hair Follicle Regeneration In Vitro

Indeterminate GlobeNewswire
NVIDIA and Global Telecom Leaders Commit to Build 6G on Open and Secure AI-Native Platforms
Mar. 1, 2026

NVIDIA and Global Telecom Leaders Commit to Build 6G on Open and Secure AI-Native Platforms

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions